Research and Markets: The Global Chiral Chemicals Market is Expected to Grow at 13.57% Compounded Annually From 2005 Through 2012
DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c90580) has announced the
addition of Chiral Chemicals to their offering.
This market insight report on Chiral Chemicals focuses on the
different Methods and Applications of Chiral Chemicals. Various Chiral
Chemical preparation and separation methods include Traditional,
Asymmetric, Biological and Other. Pharmaceuticals, Agrochemicals,
Flavors/Fragrances are the different Chiral Chemical applications
discussed. The study provides global market analysis for preparation
of Chiral Chemicals by Traditional (Diastereomeric Crystallisation,
Chromatography & Chiral Pool), Asymmetric (Synthesis & Catalysis) and
Biological (Bio-catalysis & Kinetic Resolution). The study includes
estimates and projections for the global Chiral Chemicals market.
Projections and estimates figure for geographic regions including
North America, Europe, Asia-Pacific, Japan, and Rest of World. The
industry is analyzed in US Dollars and includes 279 exclusive exhibits
with graphical representations. A total of 358 companies are covered
that are engaged in Chiral Chemical R&D, discovery, testing, and
supply of products and services.
Global Chiral Chemicals market is expected to grow at 13.57%
compounded annually from 2005 through 2012. The United States is the
leading market while due to the cost advantage and access to the
latest technologies, Asia-Pacific and Japan are the fastest growing
markets for Chiral Chemicals with a compounded annual growth of 14.8%
and 14.6% respectively.
Major companies such as Avecia, UK, and Dow Chemical's Chirotech
Technology Ltd, in the United States strive to maintain broad
portfolios of chiral chemicals and technologies. Due to the emergence
of highly sophisticated and complex mechanisms of synthesis and
separation of Chiral Chemicals, a number of small, high technology
companies have provided a niche for themselves which are primarily for
contract or outsource manufacturing. These companies aid large
corporations to develop chiral drugs based on their particular
products.
Companies Mentioned:
Accelrys, Inc. (USA)
ADMET Technologies (USA)
Advanced Chemistry Development, Inc. (ACD/Labs) (Canada)
Agilent Technologies, Inc. (USA)
AMRI Hungary, Inc. (Hungary)
Applied Biosystems Group (USA)
Argenta Discovery Ltd. (UK)
Aureus Pharma (France)
Bayer Technology Services GmbH (Germany)
BD Biosciences (USA)
Biacore International AB (Sweden)
BioFocus DPI (UK)
Bio-Rad Laboratories, Inc. (USA) Bridge Pharmaceuticals (USA)
Caliper Life Sciences, Inc. (USA)
Cellomics, Inc. (USA)
Celsis International plc (UK)
Cerep SA (France)
Charles River Laboratories, Inc. (USA)
ChemSilico LLC (The) (USA)
Chenomx, Inc. (Canada)
CompuDrug International, Inc. (USA)
Cyprotex plc (UK)
Gene Logic, Inc. (USA)
Iconix Pharmaceuticals, Inc. (USA)
ID Business Solutions Ltd. (UK)
Invitrogen, Inc. (USA)
Kendle International, Inc. (USA)
Kibron, Inc. (Finland)
LHASA Ltd. (UK)
MDL Information Systems (USA)
Millipore Corporation (USA)
Molecular Discovery Ltd. (UK)
MultiCASE, Inc. (USA)
Noray Bioinformatics S.L. (Spain)
Perkin Elmer, Inc. (USA)
Pharma Algorithms (Canada)
Promega Corporation (USA)
Qualyst, Inc. (USA)
Ranbaxy Laboratories Ltd. (India)
Schrodinger LLC (USA)
Simulations Plus, Inc. (USA)
Sirius Analytical Instruments Ltd. (UK)
Stem Cell Innovations, Inc. (USA)
Strand Life Sciences (India)
Sygnis Pharm AG (Germany)
Tecan AG (Switzerland)
Thermo Fisher Scientific, Inc. (USA)
Tripos, Inc. (USA)
Waters Corporation (USA)
Xceleron Ltd. (UK)
Countries Covered:
North America
USA
Canada
Europe
UK
Germany
France
Sweden
Finland
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
Rest of World
For more information visit
http://www.researchandmarkets.com/reports/c90580.
Research and Markets
Laura Wood
Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com
Copyright Business Wire 2008
